| Full Name | Carmen Ball |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 400 Neville St, Beckley, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104097856 | NPI | - | NPPES |
| 0152386000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 00658310 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Carmen Ball, 400 Neville St, Beckley, WV 25801-4511 Ph: (304) 256-4712 | Carmen Ball, 400 Neville St, Beckley, WV 25801-4511 Ph: (304) 256-4712 |
News Archive
Scientists have found that genetic variation at the hexokinase-1 gene is linked to variation in the blood concentration of glycated hemoglobin, an index of long-term blood glucose concentration widely used in the follow-up of diabetes patients.
Advancing healthcare quality to help improve patient outcomes and economic efficiency continues to be a primary focus in 2010 for Elsevier, the leading publisher of scientific, technical and medical information. During HIMSS 2010 (Atlanta, GA, March 1-3), Elsevier Clinical Decision Support will feature solutions that directly impact the quality of care, including evidence-based clinical content and tools; interdisciplinary documentation, planning and guidelines; drug decision support; interactive skills and procedures; data mining and outcomes analysis; and eLearning.
Research conducted by the Ph.D student Mohamed Raâfet Ben Khedher and the postdoctoral researcher Mohamed Haddad of the Institut national de la recherche scientifique has shown that an oxidation-antioxidant imbalance in the blood is an early indicator of Alzheimer's disease, rather than a consequence.
ImmunoGen, Inc., a biotechnology company that develops targeted anticancer products using its antibody expertise and Targeted Antibody Payload (TAP) technology, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its IMGN901 compound when used for the treatment of Merkel cell carcinoma (MCC). Through a separate process, the European Union (EU) Committee for Orphan Medicinal Products (COMP) concurrently also granted IMGN901 orphan medicinal product designation for the treatment of MCC.
The U.N. and non-governmental organizations (NGOs) working to fight an outbreak of cholera that has infected more than 17,000 people in the Democratic Republic of the Congo (DRC) need an additional $5.5 million to help their efforts.
› Verified 9 days ago
Paulette Lilly, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Adair St, Beckley, WV 25801 Phone: 304-256-4712 | |
Roark And Roark Inc. Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 922b S Eisenhower Dr, Beckley, WV 25801 Phone: 304-228-4895 | |
Rebbecca Rexrode, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 400 Neville St, Beckley, WV 25801 Phone: 304-256-4712 | |
Amber Lynn Willson, M.S., CCC-S Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 130 George St, Beckley, WV 25801 Phone: 304-929-2665 | |
Mrs. Marsha Smith Fink, MS CCCL SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 105 Adair St, Raleigh Co Board Of Education, Beckley, WV 25801 Phone: 304-256-4500 | |
Giana Hunsaker, MS, CF-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1769 Robert C Byrd Dr, Beckley, WV 25801 Phone: 304-860-1048 |